Novacyt S.A. (NCYT.L)

LSE • Market Data in GBP, Fundamentals in EUR Market GBP / Fundamentals EUR

£41.50

+£0.80

+1.97%

Last Update: 16 Jul 2025, 15:35

£29.31M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

£36.00 - £137.00

52 Week Range

NCYT.L Stock Price Chart

Explore Novacyt S.A. interactive price chart. Choose custom timeframes to analyze NCYT.L price movements and trends.

There is nothing to show.

NCYT.L Company Profile

Discover essential business fundamentals and corporate details for Novacyt S.A. (NCYT.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

1 Nov 2017

Employees

234.00

Website

https://www.novacyt.com

CEO

Lyn Dafydd Rees

Description

Novacyt S.A., together with its subsidiaries, engages in the development, manufacture, contract design, and commercialization of diagnostic products for cancer and infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. It serves hospitals and corporates. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

NCYT.L Financial Timeline

Browse a chronological timeline of Novacyt S.A. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 25 Sept 2025

Earnings released on 30 Apr 2025

Earnings released on 30 Jan 2025

Earnings released on 25 Oct 2024

Earnings released on 25 Jul 2024

EPS came in at -£0.21, while revenue for the quarter reached £8.69M.

Earnings released on 30 May 2024

Earnings released on 31 Dec 2023

EPS came in at -£0.25, while revenue for the quarter reached £7.20M.

Earnings released on 30 Jun 2023

EPS came in at -£0.06, while revenue for the quarter reached £1.67M.

Earnings released on 31 Mar 2023

EPS came in at -£0.06, while revenue for the quarter reached £1.67M.

Earnings released on 31 Dec 2022

EPS came in at -£0.12, while revenue for the quarter reached £2.24M.

Earnings released on 30 Sept 2022

EPS came in at -£0.12, while revenue for the quarter reached £2.28M.

Earnings released on 30 Jun 2022

EPS came in at -£0.13, while revenue for the quarter reached £16.87M, beating expectations by +0.66%.

Earnings released on 31 Dec 2021

EPS came in at £0.03, while revenue for the quarter reached £34.66M.

Earnings released on 27 Sept 2021

EPS came in at -£0.00, while revenue for the quarter reached £54.25M, missing expectations by -33.28%.

Earnings released on 30 Jun 2021

EPS came in at -£0.15, while revenue for the quarter reached £45.71M.

NCYT.L Stock Performance

Access detailed NCYT.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.